Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent Biopharma ( (AU:RGT) ) has provided an update.
Argent Biopharma Limited announced the issuance of 5.5 million unlisted warrants and 16.5 million unlisted options as part of their equity securities strategy. This move is likely to impact the company’s financial structure and market positioning by potentially increasing its capital base and providing strategic flexibility.
More about Argent Biopharma
Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is primarily engaged in producing unquoted equity securities and is listed on the Australian Securities Exchange under the code RGT.
YTD Price Performance: -20.83%
Average Trading Volume: 554
Technical Sentiment Signal: Buy
Current Market Cap: $6.65M
See more insights into RGT stock on TipRanks’ Stock Analysis page.